Downregulation of RBMS3 is associated with poor prognosis in esophageal squamous cell carcinoma

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• Chromosome 3p deletions are common in solid tumors like esophageal squamous cell carcinoma (ESCC).
• This suggests the presence of tumor suppressor genes (TSGs) on chromosome 3p.
• RBMS3, an RNA-binding protein gene at 3p24, is investigated as a potential TSG.

Purpose of the Study:

• To characterize the RBMS3 gene as a candidate tumor suppressor gene in ESCC.
• To investigate the role of RBMS3 in ESCC tumorigenesis and its association with clinical outcomes.

Main Methods:

• RBMS3 mRNA and protein levels were analyzed in primary ESCC samples.
• Clinical association studies were performed to correlate RBMS3 expression with patient outcomes.
• In vitro and in vivo assays were used to assess the effect of RBMS3 on ESCC cell tumorigenicity.
• Molecular analyses were conducted to identify downstream targets of RBMS3.

Main Results:

• RBMS3 mRNA and protein were downregulated in approximately 50% of ESCCs.
• RBMS3 downregulation correlated with poor clinical outcomes in ESCC patients.
• Restoration of RBMS3 suppressed ESCC cell growth, colony formation, and tumor development in vivo.
• RBMS3 was found to downregulate c-Myc and CDK4, inhibiting Rb phosphorylation.

Conclusions:

• RBMS3 functions as a tumor suppressor gene in ESCC.
• RBMS3 exerts its tumor suppressive effects partly through c-Myc downregulation.
• Loss of RBMS3 contributes to poor prognosis in ESCC, highlighting its clinical significance.